Tag: CGuard Prime

New findings from the C-GUARDIANS II study indicate that the CGuard Prime carotid stent system (InspireMD) achieves high procedural success, durable early luminal restoration,...

InspireMD recently announced that results from the C-GUARDIANS pivotal trial have now been published in the Journal of the American College of Cardiology (JACC)....

InspireMD has announced that it has raised approximately US$58 million in combined gross proceeds through an equity private placement (PIPE) financing and the exercise...

InspireMD has been granted premarket approval (PMA) from the US Food and Drug Administration (FDA) for its CGuard Prime carotid stent system in the...